HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.

Abstract
Ramelteon (TAK-375) is a novel melatonin receptor agonist currently under investigation for the treatment of insomnia. This study describes the neurochemical and receptor binding characteristics of ramelteon in vitro. Ramelteon showed very high affinity for human MT1 (Mel1a) and MT2 (Mel1b) receptors (expressed in Chinese hamster ovary [CHO] cells), and chick forebrain melatonin receptors (consisting of Mel1a and Mel1c receptors) with Ki values of 14.0, 112, and 23.1 pM, respectively, making the affinities of ramelteon for these receptors 3-16 times higher than those of melatonin. The affinity of ramelteon for hamster brain MT3 binding sites was extremely weak (Ki: 2.65 microM) compared to melatonin's affinity for the MT3 binding site (Ki: 24.1 nM). In addition, ramelteon showed no measurable affinity for a large number of ligand binding sites (including benzodiazepine receptors, dopamine receptors, opiate receptors, ion channels, and transporters) and no effect on the activity of various enzymes. Ramelteon inhibited forskolin-stimulated cAMP production in the CHO cells that express the human MT1 or MT2 receptors. Taken together, these results indicate that ramelteon is a potent and highly selective agonist of MT1/MT2 melatonin receptors.
AuthorsKoki Kato, Keisuke Hirai, Keiji Nishiyama, Osamu Uchikawa, Kohji Fukatsu, Shigenori Ohkawa, Yuji Kawamata, Shuji Hinuma, Masaomi Miyamoto
JournalNeuropharmacology (Neuropharmacology) Vol. 48 Issue 2 Pg. 301-10 (Feb 2005) ISSN: 0028-3908 [Print] England
PMID15695169 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Indenes
  • Receptor, Melatonin, MT1
  • Receptor, Melatonin, MT2
  • ramelteon
Topics
  • Animals
  • CHO Cells
  • Chickens
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Humans
  • Indenes (chemistry, metabolism, pharmacology)
  • Prosencephalon (drug effects, metabolism)
  • Protein Binding (drug effects, physiology)
  • Receptor, Melatonin, MT1 (agonists, metabolism)
  • Receptor, Melatonin, MT2 (agonists, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: